Product image of Lacosamide Eg (Lacosamide) supplied by GNH India

Lacosamide Eg

Active Ingredient:
Lacosamide
Origin:
EU

Lacosamide Eg (Lacosamide)

Lacosamide, the active ingredient in Lacosamide Eg, is an anticonvulsant presented as an oral formulation for oral use. It treats partial‑onset seizures as adjunctive therapy in patients with epilepsy.

GNH India supplies Lacosamide Eg as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Eurogenerics N.V./S.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Lacosamide is an anticonvulsant used in the management of focal epileptic disorders.
  • Partial‑onset seizures: reduces seizure frequency when added to existing antiepileptic regimens.
  • Adjunctive therapy for epilepsy: improves overall seizure control as part of combination therapy.

How It Works

  • Lacosamide enhances the slow inactivation of voltage‑gated sodium channels, stabilizing neuronal membranes and limiting repetitive firing. It also binds to collapsin response mediator protein‑2 (CRMP‑2), modulating neuronal differentiation and axonal transport, which together contribute to its antiepileptic effect.

Side Effects

Lacosamide may cause a range of adverse reactions, from mild to severe.

Common Side Effects

  • Dizziness: transient sensation of light‑headedness.
  • Nausea: mild gastrointestinal upset.
  • Headache: occasional throbbing pain.
  • Fatigue: feeling unusually tired.
  • Vision changes: blurred or double vision.
  • Tremor: mild shaking of limbs.

Serious or Rare Side Effects

  • Cardiac arrhythmia: irregular heart rhythm, especially PR‑interval prolongation.
  • Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis.
  • Suicidal thoughts: emergent mood changes.
  • Hepatic dysfunction: elevated liver enzymes.
  • Respiratory depression: difficulty breathing in severe cases.
  • Allergic anaphylaxis: rapid onset of swelling, hives, or airway compromise.

Precautions & Warnings

  • Before initiating therapy, consider the following safety measures.
  • Renal impairment: adjust monitoring if kidney function is reduced.
  • Cardiac disease: evaluate baseline ECG for PR‑interval abnormalities.
  • Concomitant CNS depressants: monitor for additive sedation.
  • Pregnancy and lactation: discuss potential risks with a healthcare professional.
  • Alcohol consumption: avoid excessive intake as it may increase dizziness.
  • Store at ambient temperature: keep below 25°C in the original container, protect from moisture and direct sunlight.

Avoid Interactions

Lacosamide can interact with several medicines, requiring careful management.

Major Interactions (Avoid)

  • Strong CYP3A4 inhibitors: may increase lacosamide plasma levels.
  • Cardiac conduction drugs (e.g., class IA antiarrhythmics): risk of additive PR‑interval prolongation.
  • Other sodium‑channel blockers: heightened risk of CNS depression.

Moderate Interactions (Monitor Closely)

  • Oral contraceptives: possible reduction in hormonal efficacy.
  • Antidepressants (SSRIs, SNRIs): monitor for increased dizziness or somnolence.
  • Anticoagulants: observe for any changes in bleeding tendency.

Frequently Asked Questions

Lacosamide Eg is used as an adjunctive treatment for partial‑onset seizures in patients with epilepsy. It is prescribed when seizure control is not adequate with existing antiepileptic drugs, helping to reduce the frequency of focal seizures.

Lacosamide works by enhancing the slow inactivation of voltage‑gated sodium channels, which stabilizes neuronal membranes and prevents repetitive firing. It also binds to the CRMP‑2 protein, influencing neuronal differentiation and axonal transport, contributing to its antiepileptic activity.

The dosage of Lacosamide Eg is individualized by the prescribing clinician based on the patient’s clinical condition, response, and tolerability. The prescriber determines the appropriate starting dose and any subsequent titration.

Safety data for lacosamide in pregnancy and lactation are limited. Healthcare providers should weigh the potential benefits against possible risks and discuss these considerations with the patient before initiating therapy.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, confirming trade or institutional credentials before providing pricing, availability, shipping details, and necessary import documentation.

Lacosamide offers a distinct mechanism by targeting slow sodium‑channel inactivation and CRMP‑2 modulation, which can be advantageous for patients who have not responded to other sodium‑channel blockers. Its side‑effect profile and drug‑interaction potential differ from agents such as carbamazepine or levetiracetam, making it a useful alternative in certain clinical scenarios.

Lacosamide Eg should be stored at ambient temperature, below 25 °C, in its original packaging. Keep the product away from moisture, direct sunlight, and extreme heat to maintain stability.

Lacosamide Eg is administered orally, typically as a tablet or oral solution, and should be taken with or without food as directed by the prescriber. Consistency in timing helps maintain steady drug levels.

Serious risks include cardiac arrhythmias such as PR‑interval prolongation, severe skin reactions like Stevens‑Johnson syndrome, and rare cases of suicidal ideation. Patients should be monitored for any new cardiac symptoms, rash, or mood changes.

Lacosamide Eg is contraindicated in patients with known hypersensitivity to lacosamide or any of its excipients. Caution is also advised for individuals with significant cardiac conduction disorders, severe renal impairment, or those taking interacting medications that cannot be safely managed.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Lacosamide

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT